Sat. Oct 24th, 2020

Roche Products (India) Pvt Ltd & … vs Drugs Controller General Of India … on 6 July, 2015

1 min read

1. The plaintiffs have filed the suit for injunction. The said suit
was listed before Court along with the interim application on 5th
February, 2014. After hearing, the summons in the suit were issued
to the defendants for 28th February, 2014 and in the interim
application, the defendants No.2 to 4 were restrained from relying
upon or otherwise referring to HERCEPTIN®, HERCLONTM or
BICELTIS® or any data relating to Trastuzumab marketed as
HERCEPTIN®, HERCLONTM or BICELTIS® including data relating to
its manufacturing process, safety, efficacy and sales, in any press
releases, public announcements, promotional or other material for the
defendants’ drugs, i.e. CANMAB and HERTRAZ and from claiming
any similarity with HERCEPTIN®, HERCLONTM or BICELTIS®.

Source: Indian Kanoon

Leave a Reply